231 related articles for article (PubMed ID: 16507381)
1. A pooled analysis of seven randomized crossover studies of the palatability of cefdinir oral suspension versus amoxicillin/clavulanate potassium, cefprozil, azithromycin, and amoxicillin in children aged 4 to 8 years.
Holas C; Chiu YL; Notario G; Kapral D
Clin Ther; 2005 Dec; 27(12):1950-60. PubMed ID: 16507381
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the palatability of the oral suspension of cefdinir vs. amoxicillin/clavulanate potassium, cefprozil and azithromycin in pediatric patients.
Powers JL; Gooch WM; Oddo LP
Pediatr Infect Dis J; 2000 Dec; 19(12 Suppl):S174-80. PubMed ID: 11144401
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children.
Block SL; Schmier JK; Notario GF; Akinlade BK; Busman TA; Mackinnon GE; Halpern MT; Nilius AM
Curr Med Res Opin; 2006 Sep; 22(9):1839-47. PubMed ID: 16968587
[TBL] [Abstract][Full Text] [Related]
4. Parent-reported outcomes for treatment of acute otitis media with cefdinir or amoxicillin/clavulanate oral suspensions.
Cifaldi MA; Paris MM; Devcich KJ; Bukofzer S
Paediatr Drugs; 2004; 6(6):387-93. PubMed ID: 15612839
[TBL] [Abstract][Full Text] [Related]
5. Palatability of oral antibiotics among children in an urban primary care center.
Angelilli ML; Toscani M; Matsui DM; Rieder MJ
Arch Pediatr Adolesc Med; 2000 Mar; 154(3):267-70. PubMed ID: 10710025
[TBL] [Abstract][Full Text] [Related]
6. A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study.
Block SL; Cifaldi M; Gu Y; Paris MM
Clin Ther; 2005 Jun; 27(6):786-94. PubMed ID: 16117986
[TBL] [Abstract][Full Text] [Related]
7. Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial.
Goyal V; Grimwood K; Byrnes CA; Morris PS; Masters IB; Ware RS; McCallum GB; Binks MJ; Marchant JM; van Asperen P; O'Grady KF; Champion A; Buntain HM; Petsky H; Torzillo PJ; Chang AB
Lancet; 2018 Oct; 392(10154):1197-1206. PubMed ID: 30241722
[TBL] [Abstract][Full Text] [Related]
8. Comparison of five-day cefdinir treatment with ten-day low dose amoxicillin/clavulanate treatment for acute otitis media.
Block SL; Busman TA; Paris MM; Bukofzer S
Pediatr Infect Dis J; 2004 Sep; 23(9):834-8. PubMed ID: 15361722
[TBL] [Abstract][Full Text] [Related]
9. Compliance issues related to the selection of antibiotic suspensions for children.
Steele RW; Thomas MP; Bégué RE
Pediatr Infect Dis J; 2001 Jan; 20(1):1-5. PubMed ID: 11176558
[TBL] [Abstract][Full Text] [Related]
10. Cefprozil versus high-dose amoxicillin/clavulanate in children with acute otitis media.
Hedrick JA; Sher LD; Schwartz RH; Pierce P
Clin Ther; 2001 Feb; 23(2):193-204. PubMed ID: 11293553
[TBL] [Abstract][Full Text] [Related]
11. Comparison of amoxicillin/clavulanic acid high dose with cefdinir in the treatment of acute otitis media.
Casey JR; Block SL; Hedrick J; Almudevar A; Pichichero ME
Drugs; 2012 Oct; 72(15):1991-7. PubMed ID: 23039319
[TBL] [Abstract][Full Text] [Related]
12. The comparison of single-dose ceftriaxone, five-day azithromycin, and ten-day amoxicillin/clavulanate for the treatment of children with acute otitis media.
Biner B; Celtik C; Oner N; Küçükuğurluoğlu Y; Güzel A; Yildirim C; Adali MK
Turk J Pediatr; 2007; 49(4):390-6. PubMed ID: 18246740
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial.
Goyal V; Grimwood K; Ware RS; Byrnes CA; Morris PS; Masters IB; McCallum GB; Binks MJ; Smith-Vaughan H; O'Grady KF; Champion A; Buntain HM; Schultz A; Chatfield M; Torzillo PJ; Chang AB
Lancet Respir Med; 2019 Sep; 7(9):791-801. PubMed ID: 31427252
[TBL] [Abstract][Full Text] [Related]
14. Properties of azithromycin that enhance the potential for compliance in children with upper respiratory tract infections.
Powers JL
Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S30-7. PubMed ID: 8878244
[TBL] [Abstract][Full Text] [Related]
15. Cefdinir versus amoxicillin/clavulanic acid in the treatment of suppurative acute otitis media in children.
Adler M; McDonald PJ; Trostmann U; Keyserling C; Tack K
Eur J Clin Microbiol Infect Dis; 1997 Mar; 16(3):214-9. PubMed ID: 9131324
[TBL] [Abstract][Full Text] [Related]
16. Azithromycin extended release vs amoxicillin/clavulanate: symptom resolution in acute sinusitis.
Marple BF; Roberts CS; Frytak JR; Schabert VF; Wegner JC; Bhattacharyya H; Piccirillo JF; Sanchez SP
Am J Otolaryngol; 2010; 31(1):1-8. PubMed ID: 19944891
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of amoxicillin, azithromycin, cefprozil and clarithromycin in the treatment of acute otitis media in children: a population-based study.
Quach C; Collet JP; LeLorier J
Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):163-70. PubMed ID: 15386697
[TBL] [Abstract][Full Text] [Related]
18. A double-blind taste comparison of pediatric antibiotic suspensions.
Steele RW; Estrada B; Begue RE; Mirza A; Travillion DA; Thomas MP
Clin Pediatr (Phila); 1997 Apr; 36(4):193-9. PubMed ID: 9114989
[TBL] [Abstract][Full Text] [Related]
19. Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis media.
Arguedas A; Soley C; Kamicker BJ; Jorgensen DM
Int J Infect Dis; 2011 Apr; 15(4):e240-8. PubMed ID: 21269858
[TBL] [Abstract][Full Text] [Related]
20. Study of the acceptability of antibiotic syrups, suspensions, and oral solutions prescribed to pediatric outpatients.
Cohen R; de La Rocque F; Lécuyer A; Wollner C; Bodin MJ; Wollner A
Eur J Pediatr; 2009 Jul; 168(7):851-7. PubMed ID: 18958497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
